Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
5.01
-0.32 (-6.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Genenta Science Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 6.19 | 3.69 | 29.79 | 37.24 | 15.47 | 20.14 |
Short-Term Investments | 10.72 | 15.08 | - | - | - | - |
Cash & Short-Term Investments | 16.91 | 18.78 | 29.79 | 37.24 | 15.47 | 20.14 |
Cash Growth | -23.89% | -36.98% | -19.99% | 140.80% | -23.22% | - |
Other Receivables | 1.19 | 2 | 1.56 | 1.42 | 0.76 | 0.43 |
Receivables | 1.19 | 2 | 1.56 | 1.42 | 0.76 | 0.43 |
Prepaid Expenses | 0.19 | 0.38 | 0.1 | 0.02 | 0.03 | 0.03 |
Other Current Assets | 0.28 | 0.1 | 0.26 | 0.08 | 0.28 | - |
Total Current Assets | 18.57 | 21.26 | 31.72 | 38.76 | 16.53 | 20.6 |
Property, Plant & Equipment | 0.08 | 0.06 | 0.02 | 0.02 | 0.02 | - |
Other Intangible Assets | - | 0.05 | 0.09 | - | - | - |
Other Long-Term Assets | 0.36 | 0.98 | 1.6 | 1.24 | 0.95 | 0.75 |
Total Assets | 19.02 | 22.35 | 33.44 | 40.03 | 17.5 | 21.35 |
Accounts Payable | 0.6 | 0.47 | 1.19 | 0.19 | 0.56 | 0.57 |
Accrued Expenses | 0.96 | 1.01 | 0.69 | 0.84 | 1.73 | 1.87 |
Current Portion of Leases | 0.01 | 0.01 | - | - | - | - |
Other Current Liabilities | 0.43 | 0.24 | 0.3 | 0.1 | 0.05 | 0.05 |
Total Current Liabilities | 2 | 1.74 | 2.18 | 1.14 | 2.33 | 2.49 |
Long-Term Leases | 0.01 | 0.01 | - | - | - | - |
Other Long-Term Liabilities | - | - | 0.03 | - | - | - |
Total Liabilities | 2.2 | 1.91 | 2.3 | 1.17 | 2.35 | 2.5 |
Common Stock | 67.85 | 67.34 | 66.6 | 65.88 | 0.04 | 0.04 |
Additional Paid-In Capital | - | - | - | - | 36.6 | 34.71 |
Retained Earnings | -51.18 | -47.14 | -35.47 | -27.02 | -21.49 | -15.9 |
Comprehensive Income & Other | 0.15 | 0.23 | - | - | - | - |
Shareholders' Equity | 16.82 | 20.43 | 31.14 | 38.86 | 15.15 | 18.85 |
Total Liabilities & Equity | 19.02 | 22.35 | 33.44 | 40.03 | 17.5 | 21.35 |
Total Debt | 0.02 | 0.03 | - | - | - | - |
Net Cash (Debt) | 16.89 | 18.75 | 29.79 | 37.24 | 15.47 | 20.14 |
Net Cash Growth | -23.87% | -37.07% | -19.99% | 140.80% | -23.22% | - |
Net Cash Per Share | 0.93 | 1.03 | 1.64 | 2.47 | 1.06 | 1.59 |
Filing Date Shares Outstanding | 18.29 | 18.22 | 18.22 | 18.22 | 14.66 | 12.65 |
Total Common Shares Outstanding | 18.29 | 18.22 | 18.22 | 18.22 | 14.66 | 12.65 |
Working Capital | 16.57 | 19.52 | 29.54 | 37.62 | 14.2 | 18.11 |
Book Value Per Share | 0.92 | 1.12 | 1.71 | 2.13 | 1.03 | 1.49 |
Tangible Book Value | 16.82 | 20.38 | 31.05 | 38.86 | 15.15 | 18.85 |
Tangible Book Value Per Share | 0.92 | 1.12 | 1.70 | 2.13 | 1.03 | 1.49 |
Machinery | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.